Expression of hexokinase II and Glut-1 in untreated human breast cancer

Nuclear Medicine and Biology

Volumn 29, Issue 4, 2002, Pages 443-453

  Brown, Raya S ^a   Goodman, Tonya M ^a   Zasadny, Kenneth R ^b   Greenson, Joel K ^a   Wahl, Richard L ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

18F FDG PET; Glucose metabolism; Glut 1; Hexokinase II; Human breast cancer; Immunohistochemistry

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; HEXOKINASE; ISOENZYME; DIAGNOSTIC AGENT; EXCITATORY AMINO ACID TRANSPORTER 2; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER STAGING; CANCER TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOPLASM; DRUG UPTAKE; ENZYME LOCALIZATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; PROTEIN EXPRESSION; STAINING; BIOPSY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; CARCINOMA, LOBULAR; EXCITATORY AMINO ACID TRANSPORTER 2; FLUDEOXYGLUCOSE F 18; HEXOKINASE; HUMAN; MIDDLE AGE; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL; CARCINOMA, DUCTAL, BREAST; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED;

EID: 0035988221     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00288-3     Document Type: Article

References (34)

1. Glut-1 and hexokinase expression: Relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture
2. Breast imaging with fluorine-18-FDG PET: Quantitative image analysis
3. Glucose transporters: Structure, function and consequences of deficiency
4. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: Correlation between Glut-1 expression and FDG uptake
5. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
6. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study
7. Probing mitochondria in living cells with rhodamine 123
8. 2-fluoro-2-deoxy-D-glucose (FDG) uptake into human cancer cell lines is increased by hypoxia
9. Hexokinase binding to mitochondria: A basis for proliferative energy metabolism
10. Isoenzyme pattern and subcellular localization of hexokinases in human breast cancer and nonpathological breast tissue
11. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue
12. Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer
13. Effect of GLUT1 glucose transporter overexpression on the stimulation of glucose transport in response to inhibition of oxidative phosphorylation
14. Kinetics of glucose uptake in erythrocytes. Effect of trans-concentration
15. Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase and lactate dehydrogenase in uterine cancer
16. Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase
17. Evidence that activation of 2-deoxy-D-glucose transport in rat thymocyte suspensions results from enhanced coupling between transport and hexokinase activity
18. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues
19. Human hexokinase II mRNA and gene structure
20. Insulin-like growth factor I induces tumor hexokinase RNA expression in cancer cells
21. Expression of two type II-like tumor hexokinase RNA transcripts in cancer cell lines
22. Mammalian hexokinases and their abnormal expression in cancer
23. The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation
24. Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: Intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein
25. Complete amino acid sequence of the type II isozyme of rat hexokinase, deduced from the cloned cDNA: Comparison with a hexokinase from novikoff ascites tumor
26. Tissue-specific expression of facilitative glucose transporters: A rationale
27. Monosaccharide transport into lactating-rat mammary acini
28. Untreated primary lung and breast cancers: Correlation between F-18 FDG kinetic rate constants and findings of in vitro studies
29. Determination and characterization of hexokinase in thyroid cancer and benign neoplasms
30. Hexokinases
31. An introduction to the isoenzymes of mammalian hexokinase types I-III
32. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers
33. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
34. Standardized uptake values of normal tissues method for correction